BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9418961)

  • 1. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors.
    Aloyz RS; Bamji SX; Pozniak CD; Toma JG; Atwal J; Kaplan DR; Miller FD
    J Cell Biol; 1998 Dec; 143(6):1691-703. PubMed ID: 9852160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival.
    Yoon SO; Casaccia-Bonnefil P; Carter B; Chao MV
    J Neurosci; 1998 May; 18(9):3273-81. PubMed ID: 9547236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression.
    Choi DY; Toledo-Aral JJ; Segal R; Halegoua S
    Mol Cell Biol; 2001 Apr; 21(8):2695-705. PubMed ID: 11283249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2.
    Baxter GT; Radeke MJ; Kuo RC; Makrides V; Hinkle B; Hoang R; Medina-Selby A; Coit D; Valenzuela P; Feinstein SC
    J Neurosci; 1997 Apr; 17(8):2683-90. PubMed ID: 9092589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal accumulation of p75NTR and TrkA in the septum following lesion of septo-hippocampal pathways.
    Skup M; Bacia A; Koczyk D; Jegliński W; Zaremba M; Oderfeld-Nowak B
    Acta Neurobiol Exp (Wars); 1996; 56(2):515-25. PubMed ID: 8768301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 is a co-receptor for NGF and TrkA-evoked pain.
    Peach CJ; Tonello R; Gomez K; Calderon-Rivera A; Bruni R; Bansia H; Maile L; Manu AM; Hahn H; Thomsen ARB; Schmidt BL; Davidson S; des Georges A; Khanna R; Bunnett NW
    bioRxiv; 2024 Mar; ():. PubMed ID: 38106002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells.
    Di Donato M; Cernera G; Migliaccio A; Castoria G
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31174415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An
    Mallick M; Yoithap Prabhunath TR; Kumari S; Sobhia ME
    J Biomol Struct Dyn; 2023 Nov; ():1-11. PubMed ID: 37975413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
    Gaesser JM; Fyffe-Maricich SL
    Exp Neurol; 2016 Sep; 283(Pt B):501-11. PubMed ID: 26957369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
    Dutta DJ; Zameer A; Mariani JN; Zhang J; Asp L; Huynh J; Mahase S; Laitman BM; Argaw AT; Mitiku N; Urbanski M; Melendez-Vasquez CV; Casaccia P; Hayot F; Bottinger EP; Brown CW; John GR
    Development; 2014 Jun; 141(12):2414-28. PubMed ID: 24917498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendroglial process formation is differentially affected by modulating the intra- and extracellular cholesterol content.
    Schmitz M; Signore SC; Zerr I; Althaus HH
    J Mol Neurosci; 2013 Mar; 49(3):457-69. PubMed ID: 22740150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cavtratin, a caveolin-1 scaffolding domain peptide, on oligodendroglial signaling cascades.
    Schmitz M; Zerr I; Althaus HH
    Cell Mol Neurobiol; 2011 Oct; 31(7):991-7. PubMed ID: 21523467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation.
    Fyffe-Maricich SL; Karlo JC; Landreth GE; Miller RH
    J Neurosci; 2011 Jan; 31(3):843-50. PubMed ID: 21248107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystroglycan modulates the ability of insulin-like growth factor-1 to promote oligodendrocyte differentiation.
    Galvin J; Eyermann C; Colognato H
    J Neurosci Res; 2010 Nov; 88(15):3295-307. PubMed ID: 20857503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo.
    Klopfleisch S; Merkler D; Schmitz M; Klöppner S; Schedensack M; Jeserich G; Althaus HH; Brück W
    J Neurosci; 2008 Dec; 28(50):13609-14. PubMed ID: 19074034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.
    Chang A; Nishiyama A; Peterson J; Prineas J; Trapp BD
    J Neurosci; 2000 Sep; 20(17):6404-12. PubMed ID: 10964946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor signal transduction in mature pig oligodendrocytes.
    Althaus HH; Hempel R; Klöppner S; Engel J; Schmidt-Schultz T; Kruska L; Heumann R
    J Neurosci Res; 1997 Dec; 50(5):729-42. PubMed ID: 9418961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p75 nerve growth factor receptor modulates p140trkA kinase activity, but not ligand internalization, in PC12 cells.
    Kahle P; Barker PA; Shooter EM; Hertel C
    J Neurosci Res; 1994 Aug; 38(5):599-606. PubMed ID: 7815475
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.